Erratum: Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the clinical sequencing exploratory research consortium (Genetics in Medicine (2013) 15 (860-867) DOI:10.1038/gim.2013.133);Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium

Genetics in Medicine

Volumn 15, Issue 11, 2013, Pages 860-867

  Berg, Jonathan S ^a,b   Amendola, Laura M ^c   Eng, Christine ^d   Allen, Eliezer Van ^e,f   Gray, Stacy W ^e,g,h   Wagle, Nikhil ^e,f,h   Rehm, Heidi L ^g,h,i   Dechene, Elizabeth T ^j   Dulik, Matthew C ^j   Hisama, Fuki M ^c   Burke, Wylie ^c   Spinner, Nancy B ^j   Garraway, Levi ^e,f,h   Green, Robert C ^f,h   Plon, Sharon ^d   Evans, James P ^a,b   Jarvik, Gail P ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ LABORATORY FOR MOLECULAR MEDICINE   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

actionability; actionable genes; clinical sequencing; genomic medicine; incidental findings

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ARTICLE; CONSENSUS; EXPLORATORY RESEARCH; FAMILIAL MEDITERRANEAN FEVER; GAUCHER DISEASE; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENOMICS; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INCIDENTAL FINDING; MEDICAL SOCIETY; NATIONAL HEALTH ORGANIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; CHILD; EXOME; GENETIC TESTING; GENETIC VARIATION; GENETICS, MEDICAL; GENOME, HUMAN; GENOMICS; HUMANS; INCIDENTAL FINDINGS; NATIONAL HUMAN GENOME RESEARCH INSTITUTE (U.S.); PATIENT PREFERENCE; SEQUENCE ANALYSIS, DNA; UNITED STATES;

EID: 84887474444     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2013.191     Document Type: Erratum

References (9)

1. Green ED, Guyer MS; National Human Genome Research Institute. Charting a course for genomic medicine from base pairs to bedside. Nature 2011;470:204-213.
2. Kohane IS, Masys DR, Altman RB. The incidentalome: a threat to genomic medicine. JAMA 2006;296:212-215.
3. Green RC, Berg JS, Berry GT, et al. Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet Med 2012;14:405-410.
4. Green RC, Berg JS, Grody WW, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013;15:565-574.
5. Goddard KA, Whitlock EP, Berg JS, et al. Description and pilot results from a novel method for evaluating return of incidental findings from nextgeneration sequencing technologies. Genet Med; e-pub ahead of print 4 April 2013.
6. Grody WW, Griffin JH, Taylor AK, Korf BR, Heit JA; ACMG Factor V. Leiden Working Group. American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med 2001;3:139-148.
7. Whitlock EP, Garlitz BA, Harris EL, Beil TL, Smith PR. Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2006;145:209-223.
8. Fullerton SM, Wolf WA, Brothers KB, et al. Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet Med 2012;14:424-431.
9. Murray ML, Cerrato F, Bennett RL, Jarvik GP. Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions. Genet Med 2011;13:998-1005.